Matthew Paul Kowalsky

VP, Legal and Secretary, Proteon Therapeutics.

Companies

ENANTA PHARMACEUTICALS INCGeneral counsel May 1, 2024 to now¹
Sigilon Therapeutics, Inc.General counsel Mar 1, 2023 to Aug 11, 2023²
Proteon TherapeuticsVP, Legal and Secretary May 5, 2017 to Jan 23, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ENANTA PHARMACEUTICALS INC ENTA3,591 shares⁴$41.7K at $11.60Feb 12, 2026
Sigilon Therapeutics, Inc.0 shares⁵Aug 11, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 12, 2026Shares withheld for tax 1,902 shares at $14.25 of ENANTA PHARMACEUTICALS INC⁴
Feb 12, 2026Granted 4,175 shares of ENANTA PHARMACEUTICALS INC⁴
Feb 12, 2026Granted 1,318 shares of ENANTA PHARMACEUTICALS INC⁴
Aug 11, 2023Returned to company 1,925 shares of Sigilon Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARENANTA PHARMACEUTICALS INC, General counsel
2
SEC EDGARSigilon Therapeutics, Inc., General counsel
3
SEC EDGARProteon Therapeutics, VP, Legal and Secretary
4
SEC EDGARENANTA PHARMACEUTICALS INC shares after the filing of Feb 12, 2026
5
SEC EDGARSigilon Therapeutics, Inc. shares after the filing of Aug 11, 2023